| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3937775 | Fertility and Sterility | 2011 | 9 Pages |
Abstract
Contrary to KS, the male hypogonadism observed in CHH is associated with profound E2 deficiency, which can be overcome by aromatizable androgen or combined gonadotropin therapy.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Séverine D.Pharm., Ph.D., Luigi M.D., Sylvie M.D., Stéphanie D.Pharm., Françoise M.D., Ph.D., Hélène M.D., Anne M.D., Ph.D., Philippe M.D., Nelly M.D., Antonio Agostino M.D., Sylvie M.D., Ph.D., Jacques M.D., Ph.D.,